Real World Data will be collected using Electronic Medical Record to see the effect of Omeprazole and Pantoprazole in relieving symptoms of acidity and stomach complains

Not Applicable

• Conditions: Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitisHealth Condition 2: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation

• Registration Number: CTRI/2023/03/051166
• Lead Sponsor: Dr. Reddys Laboratories Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Adult patients aged >=18 years of either gender

Patients being newly treated for GERD/APD [treatment naïve patients defined as those patients who have not received (prescribed or self-administered) any anti-acidity or anti-ulcer agent since the last two weeks]

Treatment duration of at least 4 weeks with study medication

Availability of patient information in Electronic Medical Record (EMR)

Exclusion Criteria

Combinatorial treatment with Proton Pump Inhibitors (PPIs) and prokinetics or antacids within 2 weeks preceding study enrolment

Prior treatment with Histamine 2 Receptor Antagonists (H2RAs) within 2 weeks preceding study enrolment

Prior treatment with antacids within 2 weeks preceding study enrolment

Ongoing treatment with any PPI

Refractory GERD already treated with PPI for 6-12 weeks

Any condition that, in opinion of the physician, is refractory to treatment with study medications

Any condition that, in opinion of the physician, does not justify use of patient-related information in the study

Study & Design

• Study Type: Observational
• Study Design: Not specified